Kither Biotech s.r.l. announced that it has received 18.5 million in Series B round of funding co-led by returning investor Claris Ventures SGR SpA and new investor 2invest AG on March 16, 2022. The transaction included participation from new investor Helsinn International Services Sarl and Alef 6 and returning investors CDP Venture Capital SGR, Italian Angels for Growth, Ersel Group, Club degli Investitori and ACE VCAPITAL srls. As part of the transaction, Pietro Puglisi of Claris Ventures and Heikki Lanckriet, of 4BaseBio will join company's board of directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.10 EUR | 0.00% | +0.91% | +48.99% |
- Stock Market
- Equities
- 2INV Stock
- News 2invest AG
- Kither Biotech s.r.l. announced that it has received €18.5 million in funding from a group of investors